Beijing Gene Key Life Technology
Beijing Gene Key Life Technology is a Chinese developer in Beijing that sponsors 2 registered cancer trials of GKL-006.
Overview
Beijing Gene Key Life Technology appears on ClinicalTrials.gov as the industry sponsor of 2 interventional cancer trials (phase 1/2, 2), testing GKL-006 in hepatocellular carcinoma (hcc), unresectable hepatocellular cancer, advanced pancreatic cancer, ductal adenocarcinoma of pancreas. OnCo records the company from the registry alone: the head office city comes from its registered name, and there are no website, funding or approval claims until they are sourced.
Similar pages
not linked directly; found by shared links- CompanyBeijing Konruns Pharmaceutical
Shares the tags china, registry-only.
- CompanyBeijing Mabworks Biotech
Shares the tags china, registry-only.
- CompanyBeijing Pearl Biotechnology Limited Liability Company
Shares the tags china, registry-only.
- CompanyBeijing Scitech-Mq Pharmaceuticals
Shares the tags china, registry-only.
- CompanyBeijing Tide Pharmaceutical
Shares the tags china, registry-only.
- CompanyBinhui Biopharmaceutical
Shares the tags china, registry-only.
- CompanyChengdu Zenitar Biomedical Technology
Shares the tags china, registry-only.
- CompanyHenan Genuine Biotech
Shares the tags china, registry-only.